What is coronary artery disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Coronary Artery Disease?

Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial coronary arteries, combined with structural and functional abnormalities in both the macrovascular and microvascular coronary circulation, leading to myocardial ischemia when oxygen demand exceeds supply. 1, 2

Core Pathological Process

Atherosclerosis is the fundamental disease mechanism, beginning with endothelial dysfunction and progressing through distinct stages 2, 3:

  • Initial endothelial injury occurs before any visible plaque formation 2
  • Lipid accumulation in the arterial subintima creates early fatty streaks 2
  • Inflammatory cells infiltrate and smooth muscle cells proliferate, forming complex plaques 3
  • Fibrous cap develops over a lipid-rich core, which may thin and rupture 2, 3
  • Plaque disruption triggers acute thrombosis, causing acute coronary syndromes 2

CAD is now understood as an inflammatory disorder, not simply cholesterol storage disease, fundamentally changing how we approach treatment 3, 4

Expanded Pathophysiology: Beyond Simple Blockages

The modern understanding has evolved from viewing CAD as fixed stenoses to recognizing multiple dynamic mechanisms 1, 2:

Macrovascular Abnormalities

  • Fixed flow-limiting stenoses in large epicardial arteries remain important but are not the only mechanism 2, 3
  • Diffuse atherosclerosis without visible narrowing can cause ischemia during stress 2
  • Epicardial vasospasm produces transient ischemia even without significant stenosis 2, 3
  • Structural anomalies like myocardial bridging contribute to symptoms 2

Microvascular Dysfunction

Coronary microvascular dysfunction (CMD) is increasingly recognized as prevalent across the entire CAD spectrum, affecting patients with and without obstructive disease 2, 3:

  • Functional and structural microcirculatory abnormalities cause angina even with non-obstructive epicardial disease (ANOCA/INOCA) 2, 3
  • Capillary rarefaction reduces myocardial perfusion capacity 2
  • Risk factors promoting epicardial atherosclerosis simultaneously damage the entire coronary tree, including resistance arterioles 2, 3

Systemic Contributors

  • Anemia, tachycardia, and blood pressure fluctuations create oxygen supply-demand mismatch 2, 3
  • Myocardial hypertrophy and fibrosis increase oxygen requirements 2, 3
  • Hypertension raises left ventricular wall tension and impedance 3

Multiple ischemic mechanisms frequently coexist in individual patients, making CAD a complex, multifactorial disease 2, 3

Major Risk Factors Driving Disease Development

Modifiable Risk Factors

These factors directly accelerate atherosclerosis and should be aggressively targeted 2, 5:

  • Hypertension accelerates endothelial injury and plaque formation 2
  • Elevated LDL cholesterol is a major driver of plaque accumulation 2, 5
  • Diabetes mellitus significantly increases risk and is considered a CAD risk equivalent 2, 5
  • Cigarette smoking causes direct vascular injury through oxidative stress 2
  • Low HDL cholesterol independently predicts cardiovascular events 2, 5
  • Physical inactivity substantially increases risk 2, 5
  • Obesity affects blood pressure, lipid metabolism, and glucose tolerance 2, 5
  • Atherogenic diet high in saturated fats and low in fruits/vegetables 2, 5

Non-Modifiable Risk Factors

  • Advancing age reflects cumulative atherosclerosis burden 5
  • Genetic predisposition involves at least 60 independent loci, though each contributes small individual effects 2
  • Male sex increases risk, though women have worse outcomes after acute events 1

Emerging Risk Factors

  • Left ventricular hypertrophy increases sudden cardiac death risk (HR 1.45 per 50 g/m² increment) 5
  • Elevated resting heart rate predicts sudden cardiac death 5
  • Socioeconomic and psychosocial stress independently contribute 2, 5

Persons with multiple risk factors face exponentially higher risk than those with single factors 5

Clinical Manifestations

CAD presents across a spectrum from stable chronic syndromes to life-threatening acute events 1:

Chronic Coronary Syndromes

  • Stable angina provoked by exertion, emotion, or stress 1
  • Dyspnea as an anginal equivalent 1
  • Asymptomatic ischemia detected on screening 1

Acute Coronary Syndromes

For many adults, sudden cardiac death or acute myocardial infarction is the first manifestation, because most acute events result from rupture of previously non-obstructive plaques 1:

  • Type 1 myocardial infarction from atherosclerotic plaque rupture with thrombosis 1
  • Type 2 myocardial infarction from supply-demand mismatch without plaque rupture 1
  • Myocardial infarction with non-obstructive coronary arteries (MINOCA), more common in women 1

Critical Clinical Considerations

CAD is a dynamic, progressive disease that may destabilize at any moment, not a static condition 1, 3. Patients transition between chronic and acute phases throughout their lifetime 3.

Women present differently than men 1:

  • Higher proportion of plaque erosion, microvascular dysfunction, and vasospasm rather than classic plaque rupture 1
  • Less obstructive disease on angiography but worse outcomes 1
  • More likely to present late and in heart failure 1
  • Pregnancy-related hypertensive disorders increase lifetime CAD risk 1

Vigorous exercise transiently increases risk of sudden cardiac death and myocardial infarction in both healthy individuals and those with known CAD 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Etiology of Coronary Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pathophysiology of Coronary Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Coronary Artery Disease Risk Factors and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How is coronary artery disease diagnosed?
What are the key components and management strategies of the cardiac system, including coronary artery disease (CAD), in the Cardiovascular Intensive Care Unit (CVICU)?
What are the three main etiologies of Coronary Artery Disease (CAD)?
What is the initial management for a patient with Coronary Artery Disease (CAD)?
What is Coronary Artery Disease (CAD), its etiologies, epiopathogenesis, pathogenesis, pathophysiology, clinical features, diagnosis, treatment, and complications?
What is the best treatment approach for a 20-year-old patient with hypertriglyceridemia and newly diagnosed diabetes mellitus (DM) who is starting insulin therapy?
What is the immediate management for a patient with Type II myocardial infarction, particularly those with severe coronary artery disease, hypertension, tachyarrhythmias, or severe anemia?
What is the difference between Small for Gestational Age (SGA) and Fetal Growth Restriction (FGR) in a pregnant individual with a history of complications or risk factors, such as hypertension or diabetes?
What is the approach to examining a patient with suspected seventh cranial nerve dysfunction, including symptoms of facial weakness, changes in taste, or difficulty speaking?
What examination techniques should be used for a patient with no known medical history presenting with low back pain and left flank pain after a fall?
What is the best antidiabetic medication for a patient with type 2 diabetes and chronic kidney disease (CKD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.